Stockreport

Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update

Ocuphire Pharma, Inc.  (OCUP) 
PDF FARMINGTON HILLS, Mich., May 10, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on develo [Read more]